Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...

The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...

HC Wainwright reaffirmed their buy rating on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a $32.00 ...

Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Westwater Resources (NYSEAM:WWR) with a Buy ...

H.C. Wainwright notes that Core Scientific’s (CORZ) stock “took a flyer” during trading yesterday on the news that its key HPC customer, ...

H.C. Wainwright initiated coverage of Inuvo (INUV) with a Buy rating and $2 price target Inuvo utilizes its proprietary IntentKey artificial ...

"As the market continues to grow, we believe Inuvo is well positioned given a differentiated approach which better aligns with shifting consumer demand for privacy and new regulations," Buck wrote. He ...

H.C. Wainwright downgraded Chimerix (CMRX) to Neutral from Buy after the company agreed to be acquired for $8.55 per share in cash by Jazz Pharmaceuticals (JAZZ). The total consideration of ...

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...

Fintel reports that on March 5, 2025, HC Wainwright & Co. initiated coverage of Intellia Therapeutics (LSE:0JBU) with a Buy recommendation. There are 572 funds or institutions reporting positions ...

Damian Marron, interim CEO, will participate in a fireside chat moderated by Joe Pantginis, Managing Director, Equity Research at H.C. Wainwright & Co., LLC. March 27 at 08.00am EST (13.00pm CET).